National Advisory Council on the National Health Service Corps, 6012-6013 [2019-03180]

Download as PDF 6012 Federal Register / Vol. 84, No. 37 / Monday, February 25, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Committee on Organ Transplantation Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act (FACA), this notice announces that the Secretary’s Advisory Committee on Organ Transplantation (ACOT) has scheduled a public meeting. Information about ACOT and the agenda for this meeting can be found on the ACOT website at https://www.organdonor.gov/ about-dot/acot.html. DATES: April 16, 2019, 10:00 a.m.–4:00 p.m. Eastern Time. ADDRESSES: This meeting will be held by webinar. Members of the public can access the webinar link and conference call-in number at https:// www.organdonor.gov/about-dot/ acot.html. SUMMARY: amozie on DSK3GDR082PROD with NOTICES1 FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal Official, (DFO), at Healthcare Systems Bureau, Division of Transplantation, HRSA, 5600 Fishers Lane, 8W60, Rockville, Maryland 20857; 301–443– 6839; or RWalsh@hrsa.gov. SUPPLEMENTARY INFORMATION: ACOT advises the Secretary of HHS, through the HRSA Administrator, on all aspects of organ donation, procurement, allocation, and transplantation, and on such other matters that the Secretary determines; advises the Secretary on federal efforts to maximize the number of deceased donor organs made available for transplantation and to support the safety of living organ donation; at the request of the Secretary, reviews significant proposed Organ Procurement and Transplantation Network (OPTN) policies submitted for the Secretary’s approval to recommend whether they should be made enforceable; and provides expert input on the latest advances in the science of transplantation. During the April 16, 2019, meeting, ACOT will receive updates on recent activity of OPTN and discuss efforts to increase organ donation and transplantation. Agenda items are subject to change as priorities dictate. Refer to the ACOT website for any updated information concerning the meeting. VerDate Sep<11>2014 16:22 Feb 22, 2019 Jkt 247001 Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to ACOT should be sent to Robert Walsh, DFO, using the contact information above at least three business days before the meeting. Individuals who plan to participate in the webinar and need special assistance or other reasonable accommodations should notify Robert Walsh at the address and phone number listed above at least 10 business days before the meeting. Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2019–03185 Filed 2–22–19; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Council on Blood Stem Cell Transplantation Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act (FACA), this notice announces that the Secretary’s Advisory Council on Blood Stem Cell Transplantation (ACBSCT) has scheduled a public meeting. Information about ACBSCT and the agenda for this meeting can be found on the ACBSCT website at https:// bloodcell.transplant.hrsa.gov/about/ advisory_council/meetings/index.html. DATES: May 7, 2019, 10:00 a.m.–4:00 p.m. Eastern Time. ADDRESSES: This meeting will be held by webinar. Members of the public can access the webinar link and conference call-in number at https:// www.organdonor.gov/about-dot/ acot.html. SUMMARY: FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal Official, (DFO), at Healthcare Systems Bureau, Division of Transplantation, HRSA, 5600 Fishers Lane, 8W60, Rockville, Maryland 20857; 301–443– 6839; or RWalsh@hrsa.gov. SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 to the Secretary of HHS and the HRSA Administrator on the activities of the C.W. Bill Young Cell Transplantation Program (CWBYCTP) and the National Cord Blood Inventory (NCBI) Program. The principal purpose of these programs is to make blood stem cells from adult donors and cord blood units available for patients who need a transplant to treat life-threatening conditions such as leukemia, and who lack a suitably matched relative who can be the donor. During the May 7, 2019, meeting, members of ACBSCT will discuss issues related utilization of cord blood for transplant and utilization of blood stem cells in cellular therapies. Agenda items are subject to change as priorities dictate. Refer to the ACBSCT website for any updated information concerning the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to ACBSCT should be sent to Robert Walsh, DFO, using the contact information above at least three business days before the meeting. Individuals who plan to participate in the webinar and need special assistance or other reasonable accommodations should notify Robert Walsh at the address and phone number listed above at least 10 business days before the meeting. Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2019–03184 Filed 2–22–19; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration National Advisory Council on the National Health Service Corps Department of Health and Human Services (HHS), Health Resources and Service Administration (HRSA). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, the National Advisory Council on the National Health Service Corps (NACNHSC) has scheduled public meetings for the 2019 calendar year SUMMARY: E:\FR\FM\25FEN1.SGM 25FEN1 amozie on DSK3GDR082PROD with NOTICES1 Federal Register / Vol. 84, No. 37 / Monday, February 25, 2019 / Notices (CY). Information about the NACNHSC, agendas, and materials for these meetings can be found on the NACNHSC website at https:// nhsc.hrsa.gov/about/national-advisorycouncil-nhsc/index.html. DATES: April 2–3, 2019, from 8:30 a.m.– 5:00 p.m. Eastern Time (ET) and September 17–18, 2019, from 8:30 a.m.– 5:00 p.m. ET. ADDRESSES: The April 2–3, 2019, meeting will be held by webinar. The September 17–18, 2019, meeting will be held in-person at 5600 Fishers Lane, Rockville, Maryland 20857. Additional instructions for joining the meetings either in person or remotely will be posted on the NACNHSC website 30 business days before the date of the meeting. For meeting information updates, go to the NACNHSC website meeting page at https://nhsc.hrsa.gov/ nac/meetings.html. FOR FURTHER INFORMATION CONTACT: Diane Fabiyi-King, Designated Federal Official, Division of National Health Service Corps; Bureau of Health Workforce, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; (301) 443– 3609; BHWNACNHSC@hrsa.gov. SUPPLEMENTARY INFORMATION: The NACNHSC was established by section 337 of the Public Health Service (PHS) Act (42 U.S.C. 254j), as enacted by Public Law (Pub. L.) 92–463, and as subsequently amended, and advises the Secretary of HHS (the Secretary) on issues related to NHSC responsibilities. During the CY 2019 meetings, NACNHSC will discuss and draft policy recommendations for submission to the Secretary and the HRSA Administrator. Agenda items are subject to change as priorities dictate. Refer to the NACNHSC website for any updated information concerning the CY 2019 meetings. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meetings. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to the NACNHSC should be sent to Diane Fabiyi-King, DFO, at the contact information listed above at least five business days before the meeting dates. Individuals who need special assistance or another reasonable accommodation should notify Diane Fabiyi-King, DFO at the address and phone number listed above at least 10 business days before the meetings they wish to attend. Since all in person meetings will occur in a federal government building, attendees VerDate Sep<11>2014 16:22 Feb 22, 2019 Jkt 247001 must go through a security check to enter the building. Non-U.S. Citizen attendees must notify HRSA of their planned attendance at least 20 business days prior to the meeting in order to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry. Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2019–03180 Filed 2–22–19; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Roybal Centers Meeting: Coordinating Center (M3). Date: March 14, 2019. Time: 9:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kimberly Firth, Ph.D., National Institutes of Health, National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301–402–7702, firthkm@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: February 20, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK Clinical Trial Applications Special Emphasis Panel. Date: February 25, 2019. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Peter J. Kozel, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7009, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, 301–594–4721, kozelp@niddk.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: February 20, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–03186 Filed 2–22–19; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2019–03187 Filed 2–22–19; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00035 Fmt 4703 Sfmt 9990 6013 E:\FR\FM\25FEN1.SGM 25FEN1

Agencies

[Federal Register Volume 84, Number 37 (Monday, February 25, 2019)]
[Notices]
[Pages 6012-6013]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03180]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Service Administration


National Advisory Council on the National Health Service Corps

AGENCY: Department of Health and Human Services (HHS), Health Resources 
and Service Administration (HRSA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
National Advisory Council on the National Health Service Corps 
(NACNHSC) has scheduled public meetings for the 2019 calendar year

[[Page 6013]]

(CY). Information about the NACNHSC, agendas, and materials for these 
meetings can be found on the NACNHSC website at https://nhsc.hrsa.gov/about/national-advisory-council-nhsc/index.html.

DATES: April 2-3, 2019, from 8:30 a.m.-5:00 p.m. Eastern Time (ET) and 
September 17-18, 2019, from 8:30 a.m.-5:00 p.m. ET.

ADDRESSES: The April 2-3, 2019, meeting will be held by webinar. The 
September 17-18, 2019, meeting will be held in-person at 5600 Fishers 
Lane, Rockville, Maryland 20857. Additional instructions for joining 
the meetings either in person or remotely will be posted on the NACNHSC 
website 30 business days before the date of the meeting. For meeting 
information updates, go to the NACNHSC website meeting page at https://nhsc.hrsa.gov/nac/meetings.html.

FOR FURTHER INFORMATION CONTACT: Diane Fabiyi-King, Designated Federal 
Official, Division of National Health Service Corps; Bureau of Health 
Workforce, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; (301) 
443-3609; BHWNACNHSC@hrsa.gov.

SUPPLEMENTARY INFORMATION: The NACNHSC was established by section 337 
of the Public Health Service (PHS) Act (42 U.S.C. 254j), as enacted by 
Public Law (Pub. L.) 92-463, and as subsequently amended, and advises 
the Secretary of HHS (the Secretary) on issues related to NHSC 
responsibilities. During the CY 2019 meetings, NACNHSC will discuss and 
draft policy recommendations for submission to the Secretary and the 
HRSA Administrator. Agenda items are subject to change as priorities 
dictate. Refer to the NACNHSC website for any updated information 
concerning the CY 2019 meetings.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meetings. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to the NACNHSC should 
be sent to Diane Fabiyi-King, DFO, at the contact information listed 
above at least five business days before the meeting dates. Individuals 
who need special assistance or another reasonable accommodation should 
notify Diane Fabiyi-King, DFO at the address and phone number listed 
above at least 10 business days before the meetings they wish to 
attend. Since all in person meetings will occur in a federal government 
building, attendees must go through a security check to enter the 
building. Non-U.S. Citizen attendees must notify HRSA of their planned 
attendance at least 20 business days prior to the meeting in order to 
facilitate their entry into the building. All attendees are required to 
present government-issued identification prior to entry.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2019-03180 Filed 2-22-19; 8:45 am]
 BILLING CODE 4165-15-P